Results 191 to 200 of about 26,499 (240)

Urokinase Plasminogen Activator Receptor Attenuates Allergen-induced Eosinophil Migration and Airway Hyperresponsiveness. [PDF]

Am J Respir Cell Mol Biol
Whitehead GS, Nakano K, Wilkinson CL, Patterson AM, Upadhyay S, Massri AJ, Papas BN, Gruzdev A, Ray M, Nakano H, Cook DN.   +10 more
europepmc   +1 more source

Potential Mechanisms Underlying Bleeding During Infection With Hemorrhagic Fever Viruses. [PDF]

Arterioscler Thromb Vasc Biol
Perkins MV, Mackman N.
europepmc   +1 more source

Association of suPAR with progression of cardiovascular calcification and cardiovascular outcomes in peritoneal dialysis patients. [PDF]

Ren Fail
Guan J, Xie H, Wang H, Gao S, Shen S, Chen S, Yuan S, Qi L, Wu X, Gong S.   +9 more
europepmc   +1 more source

Urokinase Plasminogen Activation System Modulation in Transformed Cell Lines. [PDF]

Int J Mol Sci
Culej Bošnjak D, Balent T, Korać P, Antica M, Matulić M.   +4 more
europepmc   +1 more source

PTSD and suPAR: A multicohort investigation of chronic inflammation. [PDF]

Brain Behav Immun
Bourassa KJ, Moffitt TE, Arseneault L, Barrett-Young A, Danese A, Garrett ME, Houts R, Matthews T, Poulton RG, Ramrakha S, Sprinckmoller S, Sugden K, Williams B, Beckham JC, Ashley-Koch AE, Kimbrel NA, Fisher HL, Theodore RF, Caspi A, Rasmussen LJH.   +19 more
europepmc   +1 more source

Decoding the metastatic nexus: how chronic stress reprograms neuroendocrine-metabolic-microbiome circuits to fuel tumor metastasis. [PDF]

Am J Cancer Res
Wang Y, Sun W, Li H, Xu F, Cui W.
europepmc   +1 more source

The interaction of fibrinolysis and the complement system in patients with acute pulmonary embolism, treated with ultrasound-assisted catheter-directed thrombolysis. [PDF]

Thromb J
Draxler DF, Barrett CD, Brodard J, Maginot ER, Chalkou K, Ho H, Keragala CB, Heg D, Kremer Hovinga JA, Moore EE, Medcalf RL, Angelillo-Scherrer A, Stortecky S.   +12 more
europepmc   +1 more source

Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activity. [PDF]

J Pharmacol Exp Ther
Schulte AJ, Lewellen M, Durose W, Nolan E, Taghizadeh L, Todhunter D, Bush C, Lang HP, Brown ME, DePauw TA, Makielski KM, Kim JH, Burt LE, Overn P, Forster CL, Seelig DM, O'Sullivan MG, Weigel BJ, Murugan P, Cutter GR, Lund TC, Vallera DA, Modiano JF.   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The receptor for urokinase‐plasminogen activator

Journal of Cellular Biochemistry, 1986
AbstractMany human cells and cell lines possess a specific receptor that binds urokinase plasminogen activator (uPA) with an affinity of about 10−10 M. Bound enzyme is not internalized, is slowly dissociated, and retains its enzymatic activity. The amino acid sequence of uPA responsible for receptor binding is located within the first 35 aminoterminal ...
Francesco Blasi, M. Patrizia Stoppelli, CUBELLIS, MARIA VITTORIA   +2 more
openaire   +3 more sources

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

International Journal of Cancer, 1995
AbstractUrokinase plasminogen activator (uPA) is a serine protease involved in cancer invasion and metastasis. uPA mediates its action while attached to a membrane‐bound receptor (uPAR). In this investigation we show that uPAR levels correlate with uPA levels in human breast cancers.
C, Duggan, T, Maguire, E, McDermott, N, O'Higgins, J J, Fennelly, M J, Duffy   +5 more
openaire   +2 more sources